183 related articles for article (PubMed ID: 25833469)
1. Tissue- and case-specific retention of intron 40 in mature dystrophin mRNA.
Nishida A; Minegishi M; Takeuchi A; Niba ET; Awano H; Lee T; Iijima K; Takeshima Y; Matsuo M
J Hum Genet; 2015 Jun; 60(6):327-33. PubMed ID: 25833469
[TBL] [Abstract][Full Text] [Related]
2. Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.
Nishida A; Minegishi M; Takeuchi A; Awano H; Niba ET; Matsuo M
Hum Genet; 2015 Sep; 134(9):993-1001. PubMed ID: 26152642
[TBL] [Abstract][Full Text] [Related]
3. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
[TBL] [Abstract][Full Text] [Related]
4. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
5. Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene.
Baskin B; Banwell B; Khater RA; Hawkins C; Ray PN
Neuromuscul Disord; 2009 Mar; 19(3):189-92. PubMed ID: 19230662
[TBL] [Abstract][Full Text] [Related]
6. Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript.
Todeschini A; Gualandi F; Trabanelli C; Armaroli A; Ravani A; Fanin M; Rota S; Bello L; Ferlini A; Pegoraro E; Padovani A; Filosto M
Neuromuscul Disord; 2016 Oct; 26(10):662-665. PubMed ID: 27616544
[TBL] [Abstract][Full Text] [Related]
7. Intronic Alternative Polyadenylation in the Middle of the
Rani AQM; Yamamoto T; Kawaguchi T; Maeta K; Awano H; Nishio H; Matsuo M
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443516
[TBL] [Abstract][Full Text] [Related]
8. Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy.
Tuffery-Giraud S; Saquet C; Chambert S; Claustres M
Hum Mutat; 2003 Jun; 21(6):608-14. PubMed ID: 12754707
[TBL] [Abstract][Full Text] [Related]
9. When a mid-intronic variation of DMD gene creates an ESE site.
Trabelsi M; Beugnet C; Deburgrave N; Commere V; Orhant L; Leturcq F; Chelly J
Neuromuscul Disord; 2014 Dec; 24(12):1111-7. PubMed ID: 25193336
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the 5'-UTR of retinal dystrophin reveals a cryptic intron that regulates translational activity.
Kubokawa I; Takeshima Y; Ota M; Enomoto M; Okizuka Y; Mori T; Nishimura N; Awano H; Yagi M; Matsuo M
Mol Vis; 2010 Dec; 16():2590-7. PubMed ID: 21151598
[TBL] [Abstract][Full Text] [Related]
11. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy.
Takeshima Y; Yagi M; Wada H; Ishibashi K; Nishiyama A; Kakumoto M; Sakaeda T; Saura R; Okumura K; Matsuo M
Pediatr Res; 2006 May; 59(5):690-4. PubMed ID: 16627883
[TBL] [Abstract][Full Text] [Related]
12. Analysis of dystrophin mRNA from skeletal muscle but not from lymphocytes led to identification of a novel nonsense mutation in a carrier of Duchenne muscular dystrophy.
Ito T; Takeshima Y; Yagi M; Kamei S; Wada H; Nakamura H; Matsuo M
J Neurol; 2003 May; 250(5):581-7. PubMed ID: 12736738
[TBL] [Abstract][Full Text] [Related]
13. A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5.
Suminaga R; Takeshima Y; Adachi K; Yagi M; Nakamura H; Matsuo M
J Hum Genet; 2002; 47(4):196-201. PubMed ID: 12166656
[TBL] [Abstract][Full Text] [Related]
14.
Niba ETE; Yamanaka R; Rani AQM; Awano H; Matsumoto M; Nishio H; Matsuo M
Cancer Cell Int; 2017; 17():58. PubMed ID: 28546788
[TBL] [Abstract][Full Text] [Related]
15. Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.
Zhang Z; Habara Y; Nishiyama A; Oyazato Y; Yagi M; Takeshima Y; Matsuo M
J Hum Genet; 2007; 52(7):607-617. PubMed ID: 17579806
[TBL] [Abstract][Full Text] [Related]
16. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
17. Novel cryptic exons identified in introns 2 and 3 of the human dystrophin gene with duplication of exons 8-11.
Ishibashi K; Takeshima Y; Yagi M; Nishiyama A; Matsuo M
Kobe J Med Sci; 2006; 52(3-4):61-75. PubMed ID: 16849873
[TBL] [Abstract][Full Text] [Related]
18. Duchenne muscular dystrophy caused by a frame-shift mutation in the acceptor splice site of intron 26.
Meregalli M; Maciotta S; Angeloni V; Torrente Y
BMC Med Genet; 2016 Aug; 17(1):55. PubMed ID: 27515321
[TBL] [Abstract][Full Text] [Related]
19. A novel cryptic exon identified in the 3' region of intron 2 of the human dystrophin gene.
Tran VK; Zhang Z; Yagi M; Nishiyama A; Habara Y; Takeshima Y; Matsuo M
J Hum Genet; 2005; 50(8):425-433. PubMed ID: 16133659
[TBL] [Abstract][Full Text] [Related]
20. Point mutations in Czech DMD/BMD patients and their phenotypic outcome.
Sedlácková J; Vondrácek P; Hermanová M; Zámecník J; Hrubá Z; Haberlová J; Kraus J; Maríková T; Hedvicáková P; Vohánka S; Fajkusová L
Neuromuscul Disord; 2009 Nov; 19(11):749-53. PubMed ID: 19783145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
